Review Article
Endometriosis-Related Infertility: The Role of the Assisted Reproductive Technologies
Table 2
Impact of prolonged GnRHa prior to IVF in endometriosis patients.
| 1st author (reference) | Year | GnRHa duration | Patients/cycles | Clinical pregnancy (%) | Design | No GnRHa | Luteal GnRHa | Prolonged GnRHa |
| Remorgida [24] | 1990 | 6 months | 60/60 | 33 | 32 | 56 | Prospective randomized | Dicker [25] | 1990 | 6 months | 64/64 | 5* | — | 33 | Prospective randomized | Nakamura [26] | 1992 | 126 ± 57 days | 32/32 | — | 27* | 67 | Retrospective | Marcus [27] | 1994 | 2–7 months | 84/181 | — | 11 | 35 | “Semirandomized” | Chedid [28] | 1995 | 3 months | 145/171 | 23* | 39 | 46 | Retrospective | Surrey [23] | 2002 | 3 months | 51/51 | — | 53.8* | 80 | Prospective randomized |
Rickes [29] | 2002 | 6 months | 47/82 | — | 47 | 75 | Postoperative | Stage I/II | 50 | 56 | Prospective randomized | Stage III/IV | 40* | 82 | |
Van der Houwen [31] | 2014 | 3–6 months | 113/113 | Fresh | 22.2 | 25 | Retrospective | Fresh + cryopreserved | 22.2 | 35.3 | |
|
|
versus prolonged GnRHa.
|